Novo Nordisk Inc. recalls Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880…
- Recall date
- December 19, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0244-2026
- FDA classification
- Class II
- Brand / firm
- Novo Nordisk Inc.
- Sold / distributed
- Nationwide within the United States.
Why it was recalled
Presence of Particulate Matter: Hair was found in a prefilled syringe
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14
Get recall alerts
Free email alert whenever Novo Nordisk Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Novo Nordisk Inc.